The development of non-separation time-resolved fluoroimmunoassays for the measurement of urinary metabolites. 1989

G Barnard, and F Kohen, and H Mikola, and T Lovgren
Department of Hormone Research, Weizmann Institute of Science, Rehovot, Israel.

We describe the principles of a new generation of sequential or simultaneous time-resolved fluoroimmunoassays, namely, simple, rapid, liquid-phase non-separation procedures which may be applied to the measurement of urinary steroid and drug metabolites. As an example, a method for the measurement of estrone-3-glucuronide in undiluted urine is reported. This method has a similar sensitivity, specificity and accuracy to a conventional separation fluoroimmunoassay or radioimmunoassay but in terms of speed, convenience, precision, reliability and clinical utility the new method has many advantages. The labelled antigen is a novel fluorescent europium chelate covalently linked to estrone-3-glucuronide. The antibody-binding reaction involves the incubation of the labelled antigen (2ng) with a limited concentration of polyclonal or monoclonal antibodies to estrone-3-glucuronyl-6-BSA and an aliquot of standard or sample (undiluted urine; 10 microliters) in microtitre wells. After a 10 min incubation, the fluorescence which emanates from the antibody-free label is measured in a time-resolved fluorometer and is proportional to the concentration of estrone-3-glucuronide in the standard or sample. The method may be applied for the monitoring of ovarian function in women.

UI MeSH Term Description Entries
D007118 Immunoassay A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance. Immunochromatographic Assay,Assay, Immunochromatographic,Assays, Immunochromatographic,Immunoassays,Immunochromatographic Assays
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D004970 Estrone An aromatized C18 steroid with a 3-hydroxyl group and a 17-ketone, a major mammalian estrogen. It is converted from ANDROSTENEDIONE directly, or from TESTOSTERONE via ESTRADIOL. In humans, it is produced primarily by the cyclic ovaries, PLACENTA, and the ADIPOSE TISSUE of men and postmenopausal women. Folliculin (Hormone),Estrone, (+-)-Isomer,Estrone, (8 alpha)-Isomer,Estrone, (9 beta)-Isomer,Estrovarin,Kestrone,Unigen,Wehgen
D005260 Female Females
D005453 Fluorescence The property of emitting radiation while being irradiated. The radiation emitted is usually of longer wavelength than that incident or absorbed, e.g., a substance can be irradiated with invisible radiation and emit visible light. X-ray fluorescence is used in diagnosis.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013050 Spectrometry, Fluorescence Measurement of the intensity and quality of fluorescence. Fluorescence Spectrophotometry,Fluorescence Spectroscopy,Spectrofluorometry,Fluorescence Spectrometry,Spectrophotometry, Fluorescence,Spectroscopy, Fluorescence

Related Publications

G Barnard, and F Kohen, and H Mikola, and T Lovgren
September 1995, Clinical chemistry,
G Barnard, and F Kohen, and H Mikola, and T Lovgren
January 1991, Steroids,
G Barnard, and F Kohen, and H Mikola, and T Lovgren
January 1999, Bioconjugate chemistry,
G Barnard, and F Kohen, and H Mikola, and T Lovgren
January 1990, Journal of bioluminescence and chemiluminescence,
G Barnard, and F Kohen, and H Mikola, and T Lovgren
July 1992, The Analyst,
G Barnard, and F Kohen, and H Mikola, and T Lovgren
January 1988, Therapeutic drug monitoring,
G Barnard, and F Kohen, and H Mikola, and T Lovgren
December 1987, Clinical chemistry,
G Barnard, and F Kohen, and H Mikola, and T Lovgren
January 1989, Analytical chemistry,
G Barnard, and F Kohen, and H Mikola, and T Lovgren
December 1987, Therapeutic drug monitoring,
G Barnard, and F Kohen, and H Mikola, and T Lovgren
April 2005, Biochimica et biophysica acta,
Copied contents to your clipboard!